Insmed Inc. buy Cantor Fitzgerald
Start price
19.09.23
/
50%
€24.40
Target price
19.09.24
€43.04
Performance (%)
172.54%
End price
20.09.24
€66.50
Summary
This prediction ended on 20.09.24 with a price of €66.50. With a performance of 172.54% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 3.681% | 3.681% | 141.429% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten